Alejandro Gomez Toledo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Escherichia Coli

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Arman Izadi, Yasaman Karami, Eleni Bratanis, Sebastian Wrighton, Hamed Khakzad, Maria Nyblom, Berit Olofsson, Lotta J Happonen, Di Tang, Martin Sundwall, Magdalena Godzwon, Yashuan Chao, Alejandro Gomez Toledo, Tobias Schmidt, Mats Ohlin, Michael Nilges, Johan Malmstöm, Wael Bahnan, Oonagh Shannon, Lars Malmström, Pontus Nordenfelt
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh 47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies. Nature communications 15 (1) (2024)
Arman Izadi, Yasaman Karami, Eleni Bratanis, Sebastian Wrighton, Hamed Khakzad, Maria Nyblom, Berit Olofsson, Lotta J Happonen, Di Tang, Martin Sundwall, Magdalena Godzwon, Yashuan Chao, Alejandro Gomez Toledo, Tobias Schmidt, Mats Ohlin, Michael Nilges, Johan Malmstöm, Wael Bahnan, Oonagh Shannon, Lars Malmström, Pontus Nordenfelt
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh 47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies. Nature communications 15 (1) (2024)
Arman Izadi, Yasaman Karami, Eleni Bratanis, Sebastian Wrighton, Hamed Khakzad, Maria Nyblom, Berit Olofsson, Lotta J Happonen, Di Tang, Martin Sundwall, Magdalena Godzwon, Yashuan Chao, Alejandro Gomez Toledo, Tobias Schmidt, Mats Ohlin, Michael Nilges, Johan Malmstöm, Wael Bahnan, Oonagh Shannon, Lars Malmström, Pontus Nordenfelt
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh 47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies. Nature communications 15 (1) (2024)
Alejandro Gomez Toledo, Eleni Bratanis, Erika Velásquez, Sounak Chowdhury, Berit Olofsson, James T Sorrentino, Christofer A Q Karlsson, Nathan E Lewis, Jeffrey D Esko, Mattias Collin, Oonagh Shannon, Johan Malmstöm
Pathogen-driven degradation of endogenous and therapeutic antibodies during streptococcal infections. Nature communications 14 (1) (2023)